Leap Forward for Drug Discovery

Liron Bar-Peled, PhD, an investigator at the Krantz Center for Cancer Research at Massachusetts General Hospital and an Associate Professor of Medicine at Harvard Medical School, is the senior author of a new study published April 22, 2024 in Cell, DrugMap: A Quantitative Pan-Cancer Analysis of Cysteine Ligandability.

Login Or Register To Read Full Story